Increased cathepsin D release by Hyp mouse osteoblast cells (Q40408731)

20 September 2017

Increased cathepsin D release by Hyp mouse osteoblast cells (English)

1 reference

20 September 2017

0 references

Naoko Matsumoto

1

1 reference

20 September 2017

Oak D Jo

2

1 reference

20 September 2017

Remi N J Shih

3

1 reference

20 September 2017

Elsa J Brochmann

4

1 reference

20 September 2017

Samuel S Murray

5

1 reference

20 September 2017

Victor Hong

6

1 reference

20 September 2017

Jane Yanagawa

7

1 reference

20 September 2017

Norimoto Yanagawa

8

1 reference

20 September 2017

1 July 2005

1 reference

American Journal of Physiology - Endocrinology and Metabolism

20 September 2017

1 reference

20 September 2017

289

1 reference

20 September 2017

1

1 reference

20 September 2017

E123-32

1 reference

Regulated secretion of conventional lysosomes

20 September 2017

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00562.2004

Partial rescue of the Hyp phenotype by osteoblast-targeted PHEX (phosphate-regulating gene with homologies to endopeptidases on the X chromosome) expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00562.2004

Secreted frizzled-related protein 4 is a potent tumor-derived phosphaturic agent

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00562.2004

Human recombinant endopeptidase PHEX has a strict S1' specificity for acidic residues and cleaves peptides derived from fibroblast growth factor-23 and matrix extracellular phosphoglycoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00562.2004

Role of abnormal neutral endopeptidase-like activities in Hyp mouse bone cells in renal phosphate transport

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00562.2004

Defective bone formation by hyp mouse bone cells transplanted into normal mice: Evidence in favor of an intrinsic osteoblast defect

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00562.2004

Defective bone formation by transplanted Hyp mouse bone cells into normal mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00562.2004

Hypophosphatemia: mouse model for human familial hypophosphatemic (vitamin D-resistant) rickets

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00562.2004

Mitogenic function of human procathepsin D: the role of the propeptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00562.2004

Inhibition of MEPE cleavage by Phex.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00562.2004

Serum levels of matrix extracellular phosphoglycoprotein (MEPE) in normal humans correlate with serum phosphorus, parathyroid hormone and bone mineral density

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00562.2004

Proteolytic regulation of apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00562.2004

Cathepsin D inactivates cysteine proteinase inhibitors, cystatins

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00562.2004

Overexpression of Phex in osteoblasts fails to rescue the Hyp mouse phenotype.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00562.2004

Estradiol Down-Regulates the Mannose-6-Phosphate/Insulin-Like Growth Factor-II Receptor Gene and Induces Cathepsin-D in Breast Cancer Cells: A Receptor Saturation Mechanism to Increase the Secretion of Lysosomal Proenzymes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00562.2004

Cartilage abnormalities are associated with abnormal Phex expression and with altered matrix protein and MMP-9 localization in Hyp mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00562.2004

FGF23, PHEX, and MEPE regulation of phosphate homeostasis and skeletal mineralization

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00562.2004

Cathepsin D Activity in Otosclerotic Bone and Perilymph

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00562.2004

MEPE, a new gene expressed in bone marrow and tumors causing osteomalacia

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00562.2004

MEPE has the properties of an osteoblastic phosphatonin and minhibin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00562.2004

Surface plasmon resonance (SPR) confirms that MEPE binds to PHEX via the MEPE-ASARM motif: a model for impaired mineralization in X-linked rickets (HYP)

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00562.2004

A rapid, sensitive, and versatile assay for protein using Coomassie brilliant blue G250.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00562.2004

X-linked hypophosphataemia: a homologous disorder in humans and mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00562.2004

A gene (PEX) with homologies to endopeptidases is mutated in patients with X-linked hypophosphatemic rickets. The HYP Consortium

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00562.2004

New functional aspects of cathepsin D and cathepsin E

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00562.2004

Mechanisms and kinetics of procathepsin D activation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00562.2004

10.1152/AJPENDO.00562.2004

21 January 2018

Identifiers

DOI

1 reference

20 September 2017

1 reference